Amneal Pharmaceuticals Q4 Adjusted EPS $0.14 Beats $0.09 Estimate, Sales $616.98M Miss $634.23M Estimate

Author: Benzinga Newsdesk | March 01, 2024 07:02am
Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 39.13 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $616.98 million which missed the analyst consensus estimate of $634.23 million by 2.72 percent. This is a 1.18 percent increase over sales of $609.76 million the same period last year.

Posted In: AMRX